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Abstract
The 16S rRNA gene is conserved across all bacteria and as such is routinely targeted in PCR surveys of bacterial diversity. PCR
primer design aims to amplify as many different 16S rRNA gene sequences from as wide a range of organisms as possible,
though there are no suitable 100% conserved regions of the gene, leading to bias. In the gastrointestinal tract,
bifidobacteria are a key genus, but are often under-represented in 16S rRNA surveys of diversity. We have designed
modified, ‘bifidobacteria-optimised’ universal primers, which we have demonstrated detection of bifidobacterial sequence
present in DNA mixtures at 2% abundance, the lowest proportion tested. Optimisation did not compromise the detection of
other organisms in infant faecal samples. Separate validation using fluorescence in situ hybridisation (FISH) shows that the
proportions of bifidobacteria detected in faecal samples were in agreement with those obtained using 16S rRNA based
pyrosequencing. For future studies looking at faecal microbiota, careful selection of primers will be key in order to ensure
effective detection of bifidobacteria.
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Introduction
With the advent of next-generation sequencing, semi quantita-
tive, in-depth characterisation of microbial communities that has
never been practically possible is now becoming increasingly
accessible to researchers. In samples from the gastrointestinal (GI)
tract, use of universal primers for amplification of the bacterial 16S
rRNA gene followed by pyrosequencing is beginning to reveal the
role of the GI microbiome in diverse diseases such as obesity [1],
atopic disease [2,3], colonic cancer [4] and necrotizing enteroco-
litis [5]. Two of the key questions surrounding the role of the GI
microbiota in health are how the microbiota is involved in
immunomodulation [6,7], and how imbalance may lead to disease
states. Organisms such as the bifidobacteria, which rapidly
colonise the gastrointestinal microbiota in the first year of life
are thought to be central in the establishment and maintenance of
a ‘healthy microbiota’ in later life.
Universal PCR primers allow amplification, and therefore
detection of all the bacteria in a mixed population. A number of
primer sets amplifying different regions of the 16S rRNA gene
exist and are in common use [8,9]. A truly universal primer pair
that binds to the 16S rRNA of all eubacteria is impossible to design
since the longest number of consecutive nucleotides in the gene
that are 100% conserved is 11 (Escherichia coli 16S rDNA positions
788 to 798), and in general, the number of sequential absolutely
conserved nucleotides in other regions of the gene is four [10]. The
decreased amplification efficiency due to differential annealing of
universal primers when a heterogeneous template is used leads to
bias against the detection of certain taxa [11]. For example, even
well designed primers matching over 95% of sequences in the
Ribosomal Database Project (RDP) [12] from the dominant
bacterial phyla present in the gut, may miss specific taxa; primer
967F [13] will detect less than five percent of Bacteroidetes whilst
primer 1492R [14] detects only 61% of Actinobacteria and 54%
of Proteobacteria [15]. Mismatches towards the 39 end are likely to
lead to greater amplification inefficiency than that at the 59 end
[16]. Pragmatic approaches to primer use are often taken,
accepting that not all bacteria will be fully represented, but that
between sample comparisons making use of the same primer pair
are valid and that particular organisms of interest are successfully
amplified.
In order to address this issue, different approaches may be
adopted to ensure that detection of the specific taxa of interest to
the study are maximised. The universal primer set used can be
optimised by either introducing a degenerate base pair at the
positions of mismatch. Alternatively, taxa-specific primers can be
added to the primer pool. Frank, et al. [16] used a primer pool
consisting of seven different primer sequences (fourfold-degenerate
primers and three primers specific for amplifying Bifidobacteriaceae,
Borrelia and Chlamydiales) and were able to dramatically increase the
detection of genera which were previously missed from clinical
samples. Increasing the number of degenerate bases in the primer
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set may however introduce a bias in the template to product ratios
when a heterogenous template is used since templates with a
greater GC content at the primer site will be preferentially
amplified [17]. Furthermore, inclusion of a large number of
degenerate bases equates to dilution of the primer pool, and the
number of templates which exactly match each primer sequence is
reduced, resulting in a potential decrease in the overall annealing
efficiency [16]. Using an inosine residue at the mismatched
positions is an alternative approach [10], but as it forms a stable
bond with all four nucleotides, this may lead to erroneous PCR
products [16].
Bifidobacteria
Bifidobacteria are considered to be a major component of the
GI microbiota in healthy breast-fed infants [18,19]. This is mainly
driven by a high level of complex oligosaccharides (10–12 g/L)
available as a natural prebiotic in human milk [20]. Their use as a
probiotic, or their stimulation by adding prebiotics (synbiotics) has
become increasingly widespread. Specific prebiotics or synbiotics
added to infant milk formula have been shown to induce a
microbiota similar to that of breastfed infants with associated
physiological changes (metabolic end products and pH) compared
to standard formula [21,22]. These changes are considered as an
important mechanism for the inhibition of pathogens in the gut
[23]. Used as a prophylactic infant feed supplement bifidobacteria
have been found to be effective at reducing both the severity as
well as the risk of developing rotavirus diarrhoea. Their use also
appears to reduce the risk of antibiotic-associated diarrhoea [24].
Moreover, bifidobacteria may be beneficial in the treatment of
atopic disease [25] and a synbiotic infant formula has been found
to prevent asthma-like symptoms in infants with atopic dermatitis
[26].
Bifidobacteria were found to constitute only a minor component
of the faecal microbiota in healthy, full term infants [27]. The
authors acknowledge that this was surprising and speculated that
this result might arise through the 8F universal primer having a
three base pair mismatch against Bifidobacterium longum, and that
the genus in general does not have 100% sequence identity to the
8F primer sequence. In our study, we have therefore sought to
assess the impact of using a standard ‘universal’ primer set with
one exactly matched to the target region of bifidobacteria, in
detecting this genus.
We designed a ‘bifidobacteria-optimised’ universal primer set by
modification of a well established primer set 357F/926R,
originally designed by the Muyzer group [28,29] for denaturing
gradient gel electrophoresis. Primer set 357F/926R is one of two
primer pairs recommended by the NIH Human Microbiome
Project protocols [30,31] for 16S rRNA amplicon pyrosequencing.
We demonstrate that our ‘bifidobacteria-optimised’ primer set
increased the bifidobacteria detection rate in both pure DNA
mixtures as well as faecal samples, without compromising the
detection of other genera. In addition, we have independently
confirmed the relative abundance of bifidobacteria detected using
fluorescence in situ hybridisation (FISH).
Results
Pyrosequencing
Pyrosequencing of the standard mixes and the faecal samples
was carried out in a single multiplexed run on the GS Junior
platform and resulted in 85 126 reads. After denoising and
chimera-removal 60 794 high quality reads remained and these
were assigned to samples using the barcode sequences, 37 977
reads for faecal samples, 22 817 for the standard DNA mixtures.
DNA mixtures
Standard universal primers detected Streptococcus pneumoniae and
Moraxella catarrhalis sequences in correct relative proportions in the
DNA mixtures. The primers however, consistently failed to
correctly quantify the bifidobacterial sequences present. The
standard universal primers failed to amplify bifidobacterial DNA
to a level above 1% in four out of the five mixtures, and the
maximum proportion of bifidobacteria that was detected was
1.6%, even when the bifidobacterial DNA constituted 90% of the
mixture.
This was in contrast to the relative proportions of species-specific
reads obtained with ‘bifidobacteria-optimised’ universal primers,
which correlated far better with the original proportions of the
species’ DNA in the mixture (R2= 0.955) (Table 1, Figure 1).
With the ‘bifidobacteria-optimised’ primers, bifidobacterial DNA
could be detected at the lowest concentration tested (2%).
Faecal samples
Operational taxonomic unit (OTU) analysis. The most
abundant taxa at phylum level were the Firmicutes and
Actinobacteria, followed by Proteobacteria and Bacteroidetes,
irrespective of which primer set was used. The ten samples all
comprised of different numbers of OTUs and OTU abundances
(Figure 2), but, the most striking difference was the increased
number of bifidobacterial reads present in the sample set analysed
with the ‘bifidobacteria-optimised’ universal primers.
Fluorescence in situ hybridisation (FISH)
analysis. Table 2 shows the proportion of faecal
bifidobacteria, expressed as a percentage of the total number of
bacteria in faeces as enumerated by FISH and the relative read
abundances by 454-sequencing.
Comparing data obtained with the two primer sets to the FISH
using Pearson correlation shows significant correlation of FISH
with the pyrosequencing using the ‘bifidobacteria-optimised’
primer set (Table 3). To confirm good agreement between two
methods Bland-Altman agreement tests were performed [32]. The
agreement between two methods is tested by comparing the
differences between two methods against the average of the
methods. The results from bifidobacteria-optimised pyrosequenc-
ing against the FISH method shows agreement in determining the
level of bifidobacteria in the faecal samples tested (Table 4).
Principal Coordinate Analysis and statistics. In order to
ensure that detection of other organisms was not compromised or
that abundance levels were not altered by using ‘bifidobacteria-
optimised’ primers, principal coordinate analysis (PCoA) was
performed. PCoA using the weighted UniFrac metric [33]
(Figure 3a) (which takes into consideration both the presence/
absence as well as abundance of sequences,) demonstrates
clustering of samples by primer set used except for pairs P1 and
P5 (circled). On OTU analysis, (Figure 2) these are shown to have
very small or only moderate numbers of bifidobacteria present.
Removing bifidobacterial sequences from the principal coordinate
analysis (Figure 3b) resulted in tight clustering of all pairs of
samples. This indicates that the main differences between the two
principal coordinate analyses are due to the detection of
bifidobacteria, and that ‘bifidobacteria-optimised’ universal
primers do not compromise the quantitative detection of other
organisms.
Using a paired T-Test to compare OTUs and read abundance
of the two sample sets (‘bifidobacteria-optimised’ universal primers
vs. regular universal primers) there was a highly significant
difference between the read abundance of bifidobacteria using
‘bifidobacteria-optimised’ primers compared to regular primers
(P=0.039, t = 0.0026, with Bonferonni correction for multiple
Bifidobacteria 16S rRNA Primer Optimisation
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testing), but no significant differences between any of the other
OTUs (P.1.4).
Primers
Primer specificity of the 926Rb primer was compared in silico
against that of 926R using the Ribosomal Database Project’s (RDP)
Probe Match tool. Only sequences longer than 1200 bp, defined as
good quality by the RDP were included and 92.4% of these were hit
with 0 mismatches with primer 926R compared to 94.5% with
926Rb. Although this overall increase was modest, the difference on
looking specifically at the order Bifidobacteriales was very marked
and highly significant: 926R hit just 0.2% of sequences compared to
97.1% with the ‘bifidobacteria-optimised’ primer.
Discussion
Appropriate primer selection in microbiota studies using a 16S
rRNA approach is essential to enable faithful representation of the
organisms present in the samples. The study of Palmer, et al. [27]
revealed that the overall efficiency of amplification of DNA from
bifidobacterial species was eight fold lower than that from non-
bifidobacterial species using the 8F/1391R primer pair. Our
results show that even a one base pair mismatch not at the 39 end
of a primer can lead to a dramatic failure to amplify these
organisms at all.
It is well known that Gram-positive organisms (such as
bifidobacteria) can be underrepresented in microbial profiling
studies due to the presence of their thick cell wall [34]. Due to
concern that poor representation of bifidobacteria from faecal
samples may be due to difficulties in cell lysis during DNA
extraction, we first assessed target sequence recovery from pure
DNA mixtures. We were able to demonstrate with the DNA
mixtures that the bias observed against the detection of
bifidobacteria was due to the PCR step. This was also confirmed
by using FISH analysis which does not require cell lysis. From the
FISH results, the bifidobacteria proportions present in the faecal
samples were in agreement with those generated from our robust
DNA extraction method combined with our ‘bifidobacteria-
optimised’ universal primers and pyrosequencing.
Burgeoning interest in the development of the normal GI
microbiota, and its impact on child and adult health, has led to
increasing numbers of studies focusing on the bacterial colonisa-
tion of the gut [7]. Metchnikoff’s [35] suggestion that it is ‘‘possible
to adopt measures to modify the flora in our bodies and to replace
the harmful microbes by useful microbes’’ over a hundred years
ago has led to the concept of manipulating the GI microbiota to
counter disease. Furthermore, the use of probiotics as a treatment
or prophylaxis strategy not only for disease, but also for
modulating the immune system has now become a focus of
intense attention [36]. Due to the escalating use of probiotics, the
Figure 1. Proportions of 454 sequencing reads obtained using both primer sets. Increased detection rate of Bifidobacterium dentium
demonstrated using the ‘bifidobacteria-optimised’ universal primers (b) compared to regular universal primers (u).
doi:10.1371/journal.pone.0032543.g001
Table 1. Proportions of DNA in each mixture.
Sample
Bifidobacterium
dentium
Streptococcus
pneumoniae
Moraxella
catarrhalis
1 2% 49% 49%
2 15% 50% 35%
3 50% 25% 25%
4 75% 5% 20%
5 90% 5% 5%
doi:10.1371/journal.pone.0032543.t001
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World Health Organization have published specific criteria that a
probiotic must fulfil [37]. One important quality of a probiotic is
that it must be able to survive the GI tract, even if this is transient.
This means that studies assessing the effectiveness of probiotics
must be able to accurately detect in at least semi-quantitative
fashion these probiotics organisms in the GI microbiota.
We have demonstrated that erroneous conclusions as to the
presence or absence, or relative proportions of, bifidobacteria
are likely if universal primers which do not sufficiently
complement the target sequence are used. The primers we
have designed are able to detect bifidobacteria at low level
abundance and can be used semi-quantitatively without
Figure 2. Heatmap displaying the relative abundance of OTUs per sample. Samples are grouped by hierarchical cluster analysis on the x-
axis and by neighbour-joining phylogenetic tree with nearest neighbour interchange on the y-axis. Samples amplified with ‘bifidobacteria-optimised’
primers are in red and with the standard primers in blue. Bifidobacterial OTUs are highlighted in the red box.
doi:10.1371/journal.pone.0032543.g002
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distorting the proportions detected of other genera. This primer
set can be successfully used in 16S rRNA pyrosequencing based
GI microbiota studies.
Materials and Methods
PCR primer design
Primers 357F/926R (357F - CCTACGGGAGGCAGCAG,
926R - CCGTCAATTCMTTTRAGT) were assessed for speci-
ficity using the ARB software package [38] and the SILVA 108
SSU Ref 16S rRNA database release [39]. Almost all bifidobac-
teria (as well as some closely related Actinobacteria) were found to
have a one base pair mismatch (C R T) to the 926R primer
(CCGTCAATTCMTTTRAGT, mismatch in bold).
A new ‘bifidobacteria-optimised’ universal primer (926Rb) was
therefore synthesised in which a T/C redundancy was incorpo-
rated at the mismatch position: CCGTCAATTYMTTTRAGT
(where Y is T or C).
Standard DNA Mixtures
DNA was extracted from pure cultures of Bifidobacterium dentium,
Streptococcus pneumoniae and Moraxella catarrhalis using the MP Bio
Fast Soil DNA kitH. An extra bead-beating step (40 seconds, speed
6.0 m/s using the FastPrepH FP120 Instrument, MP Biomedicals)
was incorporated in order to ensure efficient lysis.
Total genomic DNA concentration was measured using the
Quant-iT, PicoGreen DNA assay (Invitrogen).
Pre-defined mixtures using varying proportions of Bifidobacterium
dentium, Streptococcus pneumoniae and Moraxella catarrhalis DNAs were
prepared (Table 1). All three bacterial strains have 4 copies of the
16S rRNA operon. Consequently gene copy number is dependent
only on the number of bacteria present.
Faecal samples
Faecal samples were collected from five healthy term infants at
two time points, 4 weeks and 26 weeks of age. The samples were
immediately frozen (212uC to 220uC) prior to transfer (within
one week of sampling) to 280uC prior to evaluation.
Total DNA was extracted as described by Matsuki, et al. [40]
except that DNA was re-suspended in 0.1 ml of TE (10 mM Tris-
HCl, 1 mM EDTA, pH 8.0).
Barcoded 16S rRNA PCR and pyrosequencing
The V3–V5 regions of the bacterial 16S rRNA gene were
amplified using primers 357F with adaptor B from 454 Life
Sciences for pyrosequencing: 59 CTATCCCCTGTGTGCCTT-
GGCAGTCTCAGCCTACGGGAGGCAGCAG 39, and either
the standard 926R or the ‘bifidobacteria-optimised’ primer 926Rb
(Y in place of C, in bold): 59 CCATCTCATCCCTGCGTGT-
CTCCGACTCAGNNNNNNNNNNNNCCGTCAATTCMTT-
TRAGT 39. In addition the reverse primers included the 454 Life
Sciences adaptor A and a unique 12 base-pair error-correcting
Golay [41] barcode (denoted by ‘Ns’, see Supporting Information
S1). This allows multiplexing of samples in a single run. Primers
were obtained from Eurofins MWG Operon (Ebersberg, Ger-
many) and HPSF purified.
PCR was carried out in quadruplicate to reduce random
mispriming bias [17], and no-template PCR controls were
included. Each 25 ml reaction contained 1 mL each of forward
and reverse primers (10 mM), 1 ml of template DNA, 0.25 ml of
5 U/ml FastStart HiFi Polymerase (Roche, Mannheim, Germany),
1 ml of 20 g/mL BSA (Sigma, Dorset, United Kingdom), and
6.5 ml of 5 M Betaine (Sigma). PCR reactions were assembled
within a PCR hood under clean conditions. Thermal cycling
consisted of initial denaturation at 94uC for 2 minutes followed by
30 cycles of denaturation at 94uC for 20 seconds, annealing at
50uC for 30 seconds, and extension at 72uC for 5 minutes. The
replicate amplicons were pooled, PEG precipitated [42] (20%,
MW 8 000 g/mol) and visualized by staining with ethidium
bromide (10 mg/mL) on a 1.0% agarose gel.
Amplicon quantitation, pooling and pyrosequencing
Amplicons were combined in a single tube in equimolar
concentrations. The pooled amplicon mixture was purified twice
(AMPure XP kit, Agencourt, Takeley, United Kingdom) and the
cleaned pool requantified using the PicoGreen assay. This pool
was then diluted in TE such that it contained 105 molecules/ml.
30 ml of this pool was added to the emulsion PCR reaction to
attain a ratio of 0.3 molecules of amplicon per bead. Pyrose-
quencing was carried out on a 454 Life Sciences GS Junior
Table 2. Relative proportions of faecal bifidobacteria in ten
faecal samples as determined by FISH and 454-sequencing
using ‘bifidobacteria-optimised’ universal primers (926Rb) or
regular universal primers (926R).
Sample 926Rb 926R FISH
P1 0.2% 0.0% 0.3%
P2 81.1% 1.0% 61.2%
P3 69.0% 1.7% 70.9%
P4 63.5% 0.4% 75.8%
P5 0.2% 0.0% 0.6%
P6 62.7% 4.4% 67.3%
P7 74.1% 10.8% 47.5%
P8 90.6% 5.3% 75.0%
P9 16.9% 0.0% 10.4%
P10 8.0% 0.1% 67.0%
doi:10.1371/journal.pone.0032543.t002
Table 3. Correlation matrix (Pearson) shows the Pearson
correlation coefficients and p-values.
Variables 926Rb 926R FISH
926Rb n/a 0.593 (p = 0.071) 0.761 (p=0.011)
926R 0.593 (p = 0.071) n/a 0.297 (p = 0.404)
FISH 0.761 (p =0.011) 0.297 (p = 0.404) n/a
Values in bold are different from 0 with a significance level alpha = 0.05.
doi:10.1371/journal.pone.0032543.t003
Table 4. P-values resulting from Bland-Altman agreement
tests.
Variables 926Rb 926R FISH
926Rb n/a 0.0026 0.8974
926R 0.0026 n/a 0.0011
FISH 0.8974 0.0011 n/a
Values in bold are different from 0 with a significance level alpha = 0.05.
doi:10.1371/journal.pone.0032543.t004
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instrument (Roche) following the Roche Amplicon Lib-L protocol.
Bioinformatics
Shotgun processed data was denoised using AmpliconNoise [43]
as part of the QIIME [44] (Quantitative Insights Into Microbial
Ecology) package followed by chimera-removal with Perseus [43].
The sequences were aligned using the Greengenes core alignment
set as reference (DeSantis, et al 2006) and clustered at 97%
sequence identity into OTUs. Representative sequences (most
abundant) for each OTU were selected and classified using the
Ribosomal Database Project Classifier. Rarefaction was per-
formed so that the number of reads per sample would be identical.
Beta diversity assessment of the reads obtained from the faecal
samples using the two primer sets was carried out using the
weighted UniFrac metric to generate principal coordinate
analyses. Identification of OTUs that were significantly different
in abundance was carried out in QIIME using a paired T-test with
Bonferroni correction.
Fluorescence in situ hybridisation
To enumerate the Bifidobacterium genus by means of FISH the
16S rRNA-targeted oligonucleotide probe: Bif164-mod 59-
CATCCGGYATTACCACCC-39 was used [45,46]. The probe
was commercially synthesized and 59-labelled with Cy3 (Biolegio
B.V., Nijmegen, the Netherlands).
The FISH analysis was performed according to the method of
Thiel [47], with some modifications. Briefly, portions of each
faecal sample were fixed with 3% paraformaldehyde at 4uC for
16 hours. Following fixation, 1 ml of the cell suspension was
centrifuged at 8 0006g for 3 min and the cell pellet resuspended in
500 ml of PBS buffer, mixed with 500 ml of ethanol and then
stored at 220uC until use. 3 ml of the fixed-cell suspension of the
appropriate dilution (80, 160, 320 and 640 fold dilutions) was
applied to chrome gelatine coated 18-well slides (Cel-Line HTC
Super cured, Thermo Scientific Portsmouth, NH) and the cell
smears were dehydrated for 3 min each in 60%, 80% and 96%
ethanol. After hybridization of the probe at 50uC for 16 hours, the
slides were washed, dried, counterstained with 49,6-diamidino-2-
phenylindole (DAPI) and mounted with Citifluor AF1 (Citifluor
Ltd, London, United Kingdom).
Image acquisition and image analysis was performed using the
scan‘R screening station (Olympus, Hamburg, Germany). The
count and percentage of labelled bacteria per sample was
determined in 25 positions divided over the well by counting all
DAPI-stained bacteria and all doubly stained bacteria (DAPI and
Cy3) in the same field of view using a quadruple band filter set (Set
84000, Chroma Technology Corp., Brattleboro, VT, USA).
Data Availability
MIMARKS compliant [39] 16S rRNA amplicon data for the
faecal samples has been deposited at MG-RAST [48] under
accession numbers 4483884.3 to 4483903.3 (static link http://
metagenomics.anl.gov/linkin.cgi?project = 329).
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Figure 3. Principal Coordinate Analysis using the weighted UniFrac metric. (A) Sample pairs P9, P10 and in particular P1 and P5 cluster
tightly together. These samples contain small or moderate numbers of bifidobacteria reads. (B) After removing bifidobacteria sequences from the
analysis, all sample pairs cluster tightly showing that the main differences between the sets are due to the bifidobacteria sequences. U = regular
universal primers (926R), B – ‘bifidobacteria-optimised’ universal primers (926Rb).
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